1. Nakajima K, Lee MG, Bin BH , Hara T, Takagishi T , Chae S, Sano S, Fukada T：Possible involvement of zinc transporter ZIP10 in atopic dermatitis.
J Dermatol, 47(2):e51-e53，2020
2. Aoyama N, Hamada-Ode K, Nishikawa H, Arii K, Nakajima K, Fujimoto S, Tanigushi Y, Terada Y：Dyskeratotic cells in persistent pruritic skin lesions as a prognostic factor in adult-onset Still's disease.
Medicine, 99(6):e19051, 2020
3. Saeki H, Terui T, Morita A, Sano S, Imafuku S, Asahina A, Komine M, Etoh T, Igarashi A, Torii H, Abe M, Nakagawa H, Watanabe A, Yotsuyanagi H, Ohtsuki M：Japanese guidance for use of biologics for psoriasis (the 2019 version).
J Dermatol, 47(3):201-222, 2020
4. Ohko K, Nakajima K, Nakajima H, Hiraki Y, Kubota K, Fukao T, Miyatake S, Matsumoto N, Sano S：Skin and hair abnormalities of Cantu syndrome, a congenital hypertrichosis due to a genetic alteration mimicking the pharmacological effect of minoxidil.
J Dermatol, 47(3):306-310, 2020
5. Lee MG, Chae S, Nakajima K, Ibi M, Sano H, Hara T, Jo H, Takagishi T, Cha B, Baek JM, Yoshigai E, Ohashi T, Irié T, Sano S, Lee JS, Fukada T, Bin BH：Implication of the zinc-epigenetic axis in epidermal homeostasis.
J Dermatol Sci, 98(3):203-206, 2020
6. Hashida Y, Higuchi T, Nakajima K, Ujihara T, Murakami I, Fujieda M, Sano S and Daibata M：Human Polyomavirus 6 With the Asian/Japanese Genotype in Cases of Kimura Disease and AngiolymphoidHyperplasia With Eosinophilia.
J Invest Dermatol,40(8):1650-1653，2020
7. Nakahara T, Izuhara K, Onozuka D, Nunomura S, Tamagawa-Mineoka R, Masuda K, Ichiyama S, Saeki H, Kabata Y, Abe R, Ohtsuki M, Kamiya K, Okano T, Miyagaki T, Ishiuji Y, Asahina A, Kawasaki H, Tanese K, Mitsui H, Kawamura T, Takeichi T, Akiyama M, Nishida E, Morita A, Tonomura K, Nakagawa Y, Sugawara K, Tateishi C, Kataoka Y, Fujimoto R, Kaneko S, Morita E, Tanaka A, Hide M, Aoki N, Sano S, Matsuda-Hirose H, Hatano Y, Takenaka M, Murota H, Katoh N, Furue M : Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab A study protocol.
Medicine (Baltimore), 99(38)：e22043，2020
8. Kataoka S, Takaishi M, Nakajima K, Sano S : Phosphodiesterase-4 inhibitors reduce the expression of proinflammatory mediators by human epidermal keratinocytes independent of intracellular cAMP elevation.
